SMO ClinPlus CO.,LTD. (SHE:301257)
China · Delayed Price · Currency is CNY 69.69
+4.31 (6.59%)
At close: Jan 30, 2026
SMO ClinPlus CO.,LTD. Market Cap
SMO ClinPlus CO.,LTD. has a market cap or net worth of 5.56 billion as of February 3, 2026. Its market cap has increased by 171.47% in one year.
Market Cap
5.56B
Enterprise Value
4.92B
Revenue
819.09M
Ranking
n/a
PE Ratio
51.02
Stock Price
69.69
Market Cap Chart
Since May 17, 2022, SMO ClinPlus CO.,LTD.'s market cap has increased from 4.48B to 5.56B, an increase of 24.11%. That is a compound annual growth rate of 5.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 5.56B | 35.18% |
| Dec 31, 2025 | 4.11B | 91.80% |
| Dec 31, 2024 | 2.14B | -44.81% |
| Dec 29, 2023 | 3.88B | 32.91% |
| Dec 30, 2022 | 2.92B | -34.76% |
| May 17, 2022 | 4.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Runda Medical Technology | 9.65B |
| Amoy Diagnostics | 8.46B |
| Beijing Strong Biotechnologies,Inc. | 7.74B |
| Maccura Biotechnology Co.Ltd | 7.34B |
| Cowealth Medical China | 7.08B |
| Guangdong Hybribio Biotech | 4.80B |
| Thalys Medical Technology Group | 4.56B |
| Shanghai Labway Clinical Laboratory | 4.48B |